KTRA

Kintara Therapeutics (KTRA)

Kintara Therapeutics Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:KTRA

1 2 3 4 5 6 7 8 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/06/03	21 : 50	Edgar (US Regulatory)	Form 425 - Prospectuses and communications, business combinations	NASDAQ:KTRA	Kintara Therapeutics Inc
2024/06/03	21 : 45	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:KTRA	Kintara Therapeutics Inc
2024/06/03	21 : 35	PR Newswire (US)	TuHURA Biosciences and Kintara Therapeutics Announce Positive Results from Phase 1b Trial of IFx-2.0, a Novel Personalized Cancer Vaccine, in Checkpoint Inhibitor Resistant Advanced Merkel Cell Carcinoma (MCC) and Cutaneous Squamous Cell Carcinoma (cSCC)	NASDAQ:KTRA	Kintara Therapeutics Inc
2024/05/18	05 : 10	Edgar (US Regulatory)	Form ARS - Annual Report to Security Holders	NASDAQ:KTRA	Kintara Therapeutics Inc
2024/05/18	05 : 05	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:KTRA	Kintara Therapeutics Inc
2024/05/15	05 : 55	Edgar (US Regulatory)	Form 425 - Prospectuses and communications, business combinations	NASDAQ:KTRA	Kintara Therapeutics Inc
2024/05/15	05 : 50	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:KTRA	Kintara Therapeutics Inc
2024/05/15	05 : 45	PR Newswire (US)	Kintara Therapeutics Announces Fiscal 2024 Third Quarter Financial Results	NASDAQ:KTRA	Kintara Therapeutics Inc
2024/05/15	05 : 40	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:KTRA	Kintara Therapeutics Inc
2024/05/14	05 : 06	Edgar (US Regulatory)	Form S-4 - Registration of securities, business combinations	NASDAQ:KTRA	Kintara Therapeutics Inc
2024/04/06	02 : 09	PR Newswire (US)	Kuehn Law Encourages KTRA, ABIO, SWAV, and NS Investors to Contact Law Firm	NASDAQ:KTRA	Kintara Therapeutics Inc
2024/04/03	20 : 00	PR Newswire (US)	Kintara Therapeutics and TuHURA Biosciences Enter into Definitive Merger Agreement	NASDAQ:KTRA	Kintara Therapeutics Inc
2024/03/27	22 : 00	PR Newswire (US)	Kintara Therapeutics Announces Expansion of REM-001 Clinical Study to Include Patients on Pembrolizumab	NASDAQ:KTRA	Kintara Therapeutics Inc
2024/02/27	20 : 59	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:KTRA	Kintara Therapeutics Inc
2024/02/26	21 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:KTRA	Kintara Therapeutics Inc
2024/02/22	21 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:KTRA	Kintara Therapeutics Inc
2024/02/15	06 : 07	PR Newswire (US)	Kintara Therapeutics Announces Fiscal 2024 Second Quarter Financial Results and Provides Corporate Update	NASDAQ:KTRA	Kintara Therapeutics Inc
2024/02/12	23 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:KTRA	Kintara Therapeutics Inc
2024/02/12	23 : 00	PR Newswire (US)	Kintara Therapeutics Announces Initiation of REM-001 Clinical Trial for the Treatment of Cutaneous Metastatic Breast Cancer	NASDAQ:KTRA	Kintara Therapeutics Inc
2023/12/19	06 : 10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:KTRA	Kintara Therapeutics Inc
2023/12/19	06 : 05	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:KTRA	Kintara Therapeutics Inc
2023/12/16	06 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:KTRA	Kintara Therapeutics Inc
2023/12/07	23 : 10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:KTRA	Kintara Therapeutics Inc
2023/12/07	23 : 00	PR Newswire (US)	Kintara Therapeutics Announces Review of Strategic Alternatives	NASDAQ:KTRA	Kintara Therapeutics Inc
2023/12/05	23 : 10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:KTRA	Kintara Therapeutics Inc
2023/12/05	23 : 00	PR Newswire (US)	Kintara Therapeutics Granted Extension by Nasdaq to Regain Compliance with the Stockholders' Equity Continued Listing Requirement	NASDAQ:KTRA	Kintara Therapeutics Inc
2023/11/21	21 : 55	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:KTRA	Kintara Therapeutics Inc
2023/11/14	06 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:KTRA	Kintara Therapeutics Inc
2023/11/14	06 : 10	PR Newswire (US)	Kintara Therapeutics Announces Fiscal 2024 First Quarter Financial Results and Provides Corporate Update	NASDAQ:KTRA	Kintara Therapeutics Inc
2023/11/14	06 : 05	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:KTRA	Kintara Therapeutics Inc